You are here: Home / News / Drug mistakes common in U.S. kidney dialysis patients

Drug mistakes common in U.S. kidney dialysis patients

December 8, 2009 By

Related posts:

  1. FDA staff say Merck’s Vytorin helps kidney patients
  2. Advisers back Merck’s Vytorin in some kidney patients
  3. Kidney improvement sustained by Abbott drug: study
  4. FDA panel backs Pfizer’s drug for kidney cancer
  5. FDA panel backs Pfizer’s drug for kidney cancer

Filed Under: News Tagged With: ,